U.S. Revenue Cycle Management for Oncology And Urology Market Size, Share & Trends Analysis Report By Sourcing (In-house, External RCM Apps/ Software, Outsourced RCM Services), By End Use, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                   1.2 Research Process
                       1.2.1 Information Procurement
                           1.2.1.1 Purchased Database
                           1.2.1.2 GVR’s Internal Database
                       1.2.2 Primary Research
                   1.3 Research Methodology for Parent Market (U.S. RCM Market)
                       1.3.1 Company Market Share
                       1.3.2 Market Estimations
                           1.3.2.1 RCM Market Estimation
                           1.3.2.2 RCM Outsourcing Market Estimation
                           1.3.2.3 In-House U.S. RCM Market Estimation
                           1.3.2.4 U.S. RCM Market Estimation
                           1.3.2.5 Oncology And Urology Practices in the U.S. estimation
                       1.3.3 Country Market: CAGR Calculation
                   1.4 Country-based Segment Share Calculation
                       1.4.1 Segmental Market Estimation for Oncology and Urology:
                   1.5 List of Data Sources
Chapter 2 Executive Summary
                   2.1 Market Snapshot
                   2.2 Segment Snapshot
                   2.3 Competitive Landscape Snapshot
Chapter 3 U.S. Revenue Cycle Management for Oncology and Urology Market Variables, Trends & Scope
                   3.1 U.S. Revenue Cycle Management for Oncology and Urology Market Snapshot
                   3.2 Penetration and Growth Prospect Mapping
                   3.3 Market Dynamics
                       3.3.1 Market Driver Analysis
                           3.3.1.1 Technological Advancements
                           3.3.1.2 Increase in outsourcing of RCM
                           3.3.1.3 Increasing adoption of mHealth
                           3.3.1.4 Growth of High-Deductible Health Plans (Hdhps)
                       3.3.2 Market Restraint Analysis
                           3.3.2.1 Increasing Payer Partnerships
                           3.3.2.2 Lack Of Professionals To Handle RCM Processes
                   3.4 U.S. Revenue Cycle Management Market Analysis Tools
                       3.4.1 Industry Analysis - Porter’s Five Forces
                           3.4.1.1 Bargaining Power Of Suppliers-Moderate
                           3.4.1.2 Bargaining Power Of Buyers- Moderate
                           3.4.1.3 Threat Of Substitution- Low
                           3.4.1.4 Threat Of New Entrants- Moderate
                           3.4.1.5 Competitive Rivalry- High
                   3.5 Number of Oncology and Urology Practices in the U.S.
                       3.5.1 Estimated total number of oncology hospitals & practices, 2021
                       3.5.2 Estimated total number of oncology hospitals & practices, 2021, By Size
                       3.5.3 Estimated total number of urology hospitals & practices, 2021
                   3.6 Penetration Rates of In-house vs Outsourced RCM Services for Oncology
                       3.6.1 Community Practices
                       3.6.2 Hospitals
                   3.7 Penetration Rates of In-house vs Outsourced RCM Services for Urology
                       3.7.1 Community Practices
                       3.7.2 Hospitals
                   3.8 Contract Agreement Framework
                       3.8.1 Hospitals
                           3.8.1.1 Medium-Sized Hospitals
                           3.8.1.2 Large-Sized Hospitals
                   3.9 Impact of COVID-19 Pandemic on the U.S. Revenue Cycle Management for Oncology and Urology Market
Chapter 4 U.S. Revenue Cycle Management for Oncology and Urology Market: Sourcing Market Estimates & Trend Analysis
                   4.1 U.S. Revenue Cycle Management for Oncology and Urology Market: Sourcing Analysis
                       4.1.1 In-House
                           4.1.1.1 In-House market value estimates and forecasts, 2016 - 2030 (USD Billion)
                       4.1.2 External RCM Apps/ Software
                           4.1.2.1 External RCM Apps/ Software market value estimates and forecasts, 2016 - 2030 (USD Billion)
                       4.1.3 Outsourced RCM Services
                           4.1.3.1 Outsourced RCM Services market value estimates and forecasts, 2016 - 2030 (USD Billion)
Chapter 5 U.S. Revenue Cycle Management for Oncology and Urology Market: End-Use Market Estimates & Trend Analysis
                   5.1 U.S. Revenue Cycle Management for Oncology and Urology Market: End-Use Analysis
                       5.1.1 Physicians and Clinical Services
                           5. Physicians and clinical services market value estimates and forecasts, 2016 - 2030 (USD Billion)
                       5.1.2 Hospitals
                           5.1.2.1 Hospitals market value estimates and forecasts, 2016 - 2030 (USD Billion)
Chapter 6 U.S. Revenue Cycle Management for Oncology and Urology Market: Competitive Analysis
                   6.1 Recent Developments & Impact Analysis, By Key Market Participants
                   6.2 Company Market Position Analysis
                   6.3 List of Key Competitors in Urology and Oncology with their Key Clientele
Chapter 7 Competitive Landscape
                   7.1 Company Profiles
                       7.1.1 United Urology Group
                           7.1.1.1 Company Overview
                           7.1.1.2 Financial Performance
                           7.1.1.3 Product Benchmarking
                           7.1.1.4 Strategic Initiatives
                       7.1.2 Cardinal Health
                           7.1.2.1 Company Overview
                           7.1.2.2 Financial Performance
                           7.1.2.3 Product Benchmarking
                       7.1.3 Flatiron
                           7.1.3.1 Company Overview
                           7.1.3.2 Financial Performance
                           7.1.3.3 Product Benchmarking
                           7.1.3.4 Strategic Initiatives
                       7.1.4 Oncospark.com
                           7.1.4.1 Company Overview
                           7.1.4.2 Financial Performance
                           7.1.4.3 Product Benchmarking
                           7.1.4.4 Strategic Initiatives
                       7.1.5 Fedora Solutions
                           7.1.5.1 Company Overview
                           7.1.5.2 Financial Performance
                           7.1.5.3 Product Benchmarking
                       7.1.6 BillingParadise
                           7.1.6.1 Company Overview
                           7.1.6.2 Financial Performance
                           7.1.6.3 Product Benchmarking
                       7.1.7 Gentem
                           7.1.7.1 Company Overview
                           7.1.7.2 Financial Performance
                           7.1.7.3 Product Benchmarking
                           7.1.7.4 Strategic Initiatives
                       7.1.8 Integra Connect, LLC
                           7.1.8.1 Company Overview
                           7.1.8.2 Financial Performance
                           7.1.8.3 Product Benchmarking
                           7.1.8.4 Strategic Initiatives
                       7.1.9 R1 RCM, Inc.
                           7.1.9.1 Company Overview
                           7.1.9.2 Financial Performance
                           7.1.9.3 Product Benchmarking
                           7.1.9.4 Strategic Initiatives

List of Tables

Table 1 Estimated total number of oncology hospitals and practices, 2021
Table 2 Estimated total number of oncology hospitals and practices, by size, 2021
Table 3 Estimated total number of urology hospitals and practices
Table 4 Penetration rate of in-house vs outsourced RCM services for oncology in community practices (%)
Table 5 Penetration rate of in-house vs outsourced RCM services for oncology in hospitals (%)
Table 6 Penetration rate of in-house vs outsourced RCM services for urology in community practices (%)
Table 7 Penetration rate of in-house vs outsourced RCM services for urology in hospitals (%)
Table 8 Contract agreement framework in medium-sized hospitals
Table 9 Contract agreement framework in large-sized hospitals

List of Figures

Fig. 1 U.S. revenue cycle management for oncology and urology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Research methodology: U.S. RCM market
Fig. 6 U.S. revenue cycle management for oncology and urology market trends & outlook
Fig. 7 Penetration & growth prospect mapping
Fig. 8 Market driver analysis (Current & future impact)
Fig. 9 Market restraint analysis (Current & future impact)
Fig. 10 U.S. revenue cycle management for oncology and urology market, sourcing outlook: Key takeaways (USD Billion)
Fig. 11 U.S. revenue cycle management for oncology and urology market: Sourcing movement analysis (USD Billion)
Fig. 12 In-house market estimates and forecasts, 2016 - 2030 (USD Billion)
Fig. 13 External RCM apps/software market estimates and forecasts, 2016 - 2030 (USD Billion)
Fig. 14 Outsourced RCM services market estimates and forecasts, 2016 - 2030 (USD Billion)
Fig. 15 U.S. revenue cycle management for oncology and urology market, end-use outlook: Key takeaways (USD Billion)
Fig. 16 U.S. revenue cycle management for oncology and urology market: End-use movement analysis (USD Billion)
Fig. 17 Physicians and clinical services market estimates and forecasts, 2016 - 2030 (USD Billion)
Fig. 18 Hospitals market estimates and forecasts, 2016 - 2030 (USD Billion)
Fig. 19 Company market position analysis, 2022
Fig. 20 Estimated share of in-house vs outsourced RCM solutions in oncology